SCIESCOPUSQ3
Clinical Breast Cancer
CIG MEDIA GROUP, LP, United States
Clinical Breast Cancer is an academic journal published by CIG MEDIA GROUP, LP (United States). Identifiers: ISSN 1526-8209, eISSN 1938-0666. Indexed in SCIE, SCOPUS. Metrics: JIF 2.5, CiteScore 5.6, SJR 1.018, SNIP 0.96. Subject areas: ONCOLOGY. tlooto lists 3,298 papers from this journal.
CiteScore
5.60
Scopus citation metric
SJR
1.018
SCImago rank
SNIP
0.96
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1526-8209
- eISSN
- 1938-0666
- Abbreviation
- CLIN BREAST CANCER
- Publisher
- CIG MEDIA GROUP, LP
- Country
- United States
Web of Science categories
SCIEONCOLOGY
Scopus ASJC categories
1306 Cancer Research2730 Oncology
Keywords
Oncology
Papers in this journal
Recent papers
- From Bitter Taste Perception to Anti-Cancer Weapons: New Directions for Bitter Taste Receptors in Malignant Tumor Treatment.
2026 · 1 citations
- Hard and Soft MRI Signs of Nipple-Areolar Complex Involvement in Breast Cancer.
2026
- Differences in Survival and Associated Characteristics Between Asian American and White Patients With Breast Cancer.
2026
- Event-Free Survival After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Breast Cancer.
2026 · 1 citations
- Are Expectations in Breast Reconstruction Manageable? A Mixed-Methods GoBreast II Study on Women's Goals of Breast Reconstruction After Mastectomy.
2026
Most cited papers
- HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues.
2004 · 641 citations
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
2009 · 617 citations
- The global breast cancer burden: variations in epidemiology and survival.
2005 · 607 citations
- Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design.
2009 · 429 citations
- Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab.
2005 · 363 citations